GeoVax Labs Inc - Company Profile

Powered by

All the data and insights you need on GeoVax Labs Inc in one report.

$ $295
Buy Report View Sample
  • Save hours of research time and resources with
    our up-to-date GeoVax Labs Inc Strategy Report

  • Understand GeoVax Labs Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

GeoVax Labs Inc: Overview

Select Item

GeoVax Labs Inc (GeoVax) is a biotechnology company that develops immunotherapies and vaccines against cancers and various infectious diseases. GeoVax develops vaccines using its novel patented Modified Vaccinia Ankara-Virus like Particle (MVA-VLP) vector vaccine platform focused on therapy areas such as infectious diseases like HIV, Lassa fever, Ebola, Zika virus, malaria, Hepatitis B, coronavirus, and cancers related to solid tumors and HPV-associated head and neck cancer. It has partnerships for preclinical and clinical testing with various government, academic and corporate entities, including the Centers for Disease Control and Prevention (CDC), Leidos Inc, Scripps Research Institute, and Emory University. GeoVax is headquartered in Smyrna, Georgia, the US.

 Gain a 360-degree view of GeoVax Labs Inc and make more informed decisions for your business Gain a 360-degree view of GeoVax Labs Inc and make more informed decisions for your business Find out more
Headquarters United States of America
Address 1900 Lake Park Drive, Suite 380, Smyrna, Georgia, 30080
Website www.geovax.com
Telephone 1 678 3847220
No of Employees 14
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange GOVX (NASD)
Revenue (2022) $81,500 -78.9% (2022 vs 2021)
EPS XYZ
Net Income (2022) XYZ 24.5% (2022 vs 2021)
Market Cap* $10.4M
Net Profit Margin (2022) XYZ -257.0% (2022 vs 2021)
* As of and is in US$
View GeoVax Labs Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Find out more

GeoVax Labs Inc premium industry data and analytics

30+

Pipeline Drugs

Identify which of GeoVax Labs Inc’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for GeoVax Labs Inc’s relevant decision makers and contact details.

20+

Clinical Trials

Determine GeoVax Labs Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

19+

Catalyst Calendar

Proactively evaluate GeoVax Labs Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

4

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

2

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

Products and Services

Products
Product Pipeline:
HPV-related cancers
Solid Tumors
XYZ
XYZ
XYZ
Understand GeoVax Labs Inc portfolio and identify potential areas for collaboration Understand GeoVax Labs Inc portfolio and identify potential areas for collaboration Find out more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Contracts/Agreements In May, the company entered into an agreement with Advanced Bioscience Laboratories, Inc to support current good manufacturing practices production of the company’s vaccine candidates, including GEO-MVA and GEO-CM04S1.
2023 Contracts/Agreements In February, the company announced its collaboration with EmVenio to expand Phase 2 Covid-19 Booster Vacciene Clinical Trial.
2023 Official Trials/Tests In February, the company expanded Gedeptin clinical research for head and neck cancers.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Find out more
Image for loader

Competitor Comparison

Key Parameters GeoVax Labs Inc Pfizer Inc Johnson & Johnson Merck & Co Inc Sanofi
Headquarters United States of America United States of America United States of America United States of America France
City Smyrna New York New Brunswick Kenilworth Paris
State/Province Georgia New York New Jersey New Jersey Ile-de-France
No. of Employees 14 83,000 152,700 69,000 91,573
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Find out more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Find out more
Executives
Name Position Board Since Age
David A. Dodd Chairman; President; Chief Executive Officer Executive Board 2018 73
Mark W. Reynolds, CPA Corporate Secretary; Chief Financial Officer Senior Management 2006 61
Kelly T. McKee, M.D. Chief Medical Officer Senior Management 2022 73
Mark J. Newman, Ph.D. Chief Scientific Officer Senior Management 2020 68
Harriet L. Robinson, Ph.D. Chief Scientific Officer - Emeritus, GeoVax Senior Management 2007 -
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Non Dignissim Eros Proin vel Convallis 2023 XY
Gain insight into GeoVax Labs Inc key executives to enhance your sales strategy Gain insight into GeoVax Labs Inc key executives to enhance your sales strategy Find out more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward